Corrects company descriptor to biotech in bullet 1
** Shares of biotech Kala Bio KALA.O rise 41% to 41 cents premarket
** Co says it will launch its first commercial AI platform, "Researgency.ai", in about two weeks, expanding beyond drug development
** KALA's Researgency.ai is designed to automate routine biotech tasks such as paperwork, compliance work and research monitoring
** Co says first custom AI agent will be delivered in 14 days and expects recurring revenue from the platform
** Launch marks shift to a dual model combining its biologics pipeline with a scalable AI service, co says
** Shares down ~92% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))